BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 180 filers reported holding BRIDGEBIO PHARMA INC in Q4 2022. The put-call ratio across all filers is 0.41 and the average weighting 0.3%.
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $4,969 | +13.0% | 499,889 | +3.2% | 0.01% | 0.0% |
| Q2 2022 | $4,399 | -20.0% | 484,477 | -10.6% | 0.01% | +25.0% |
| Q1 2022 | $5,500 | -32.7% | 541,891 | +10.7% | 0.00% | 0.0% |
| Q4 2021 | $8,169 | -62.6% | 489,721 | +5.1% | 0.00% | -63.6% |
| Q3 2021 | $21,835 | -14.7% | 465,876 | +11.0% | 0.01% | -8.3% |
| Q2 2021 | $25,597 | +32.9% | 419,892 | +34.3% | 0.01% | +9.1% |
| Q1 2021 | $19,259 | +128.5% | 312,645 | +163.8% | 0.01% | +120.0% |
| Q4 2020 | $8,429 | +271.5% | 118,532 | +96.0% | 0.01% | +150.0% |
| Q3 2020 | $2,269 | +1100.5% | 60,469 | +941.0% | 0.00% | – |
| Q2 2020 | $189 | +142.3% | 5,809 | +115.1% | 0.00% | – |
| Q1 2020 | $78 | – | 2,700 | – | 0.00% | – |
Download | ||||||